S
Sanjoy K. Paul
Researcher at University of Melbourne
Publications - 165
Citations - 14891
Sanjoy K. Paul is an academic researcher from University of Melbourne. The author has contributed to research in topics: Type 2 diabetes & Medicine. The author has an hindex of 31, co-authored 119 publications receiving 12912 citations. Previous affiliations of Sanjoy K. Paul include QIMR Berghofer Medical Research Institute & University of Oxford.
Papers
More filters
Journal ArticleDOI
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
TL;DR: Despite an early loss of glycemic differences, a continued reduction in microvascular risk and emergent risk reductions for myocardial infarction and death from any cause were observed during 10 years of post-trial follow-up.
Journal ArticleDOI
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Fiona Turnbull,Carlos Abraira,Robert J. Anderson,Robert J. Anderson,Robert P. Byington,John Chalmers,William C. Duckworth,Gregory W. Evans,Hertzel C. Gerstein,Rury R. Holman,Thomas E. Moritz,Bruce Neal,Toshiharu Ninomiya,Anushka Patel,Sanjoy K. Paul,F. Travert,Mark Woodward,Mark Woodward +17 more
TL;DR: Targeting more-intensive glucose lowering modestly reduced major macrovascular events and increased major hypoglycaemia over 4.4 years in persons with type 2 diabetes, and suggests that glucose-lowering regimens should be tailored to the individual.
Journal ArticleDOI
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts,Sanjoy K. Paul,Murat Akova,Matteo Bassetti,Jan J. De Waele,George Dimopoulos,Kirsi-Maija Kaukonen,Despoina Koulenti,Claude Martin,Philippe Montravers,Jordi Rello,Andrew Rhodes,Therese Starr,Steven C. Wallis,Jeffrey Lipman,Dali Study +15 more
TL;DR: Infected critically ill patients may have adverse outcomes as a result of inadeqaute antibiotic exposure; a paradigm change to more personalized antibiotic dosing may be necessary to improve outcomes for these most seriously ill patients.
Journal ArticleDOI
Long-term follow-up after tight control of blood pressure in type 2 diabetes
TL;DR: Early improvement in blood-pressure control in patients with both type 2 diabetes and hypertension was associated with a reduced risk of complications, but it appears that good blood- pressure control must be continued if the benefits are to be maintained.
Journal ArticleDOI
Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes
Rury R. Holman,Kerensa I. Thorne,Andrew Farmer,Melanie J. Davies,Joanne F. Keenan,Sanjoy K. Paul,Jonathan C. Levy +6 more
TL;DR: The addition of biphasic or prandial insulin aspart reduced levels more than the addition of basal insulin detemir but was associated with greater risks of hypoglycemia and weight gain.